Tower Research Capital »

Alterity Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Alterity Therapeutics (ATHE) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Alterity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Alterity Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alterity Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $31 10 3.10

More positions owned by Tower Research Capital

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Spdr Series Trust State Street Spd (SJNK)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Ishares Tr Russell 2000 Etf (IWM)
Advanced Micro Devices (AMD)
Wisdomtree Tr Floatng Rat Trea (USFR)
JPMorgan Chase & Co. (JPM)

View all positions for Tower Research Capital

Top funds holding Alterity Therapeutics

Twin Lakes Capital Management
HB Wealth Management
Greenleaf Trust
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Acadian Asset Management
Rhumbline Advisers
GAMMA Investing
Advisor Group Holdings
Ronald Blue Trust
Motiv8 Investments
Farther Finance Advisors
CoreCap Advisors
Tower Research Capital
Steward Partners Investment Advisory

View all funds holding Alterity Therapeutics